Insider Transactions in Q3 2022 at Lexicon Pharmaceuticals, Inc. (LXRX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2022
|
Artal International S.C.A. |
BUY
Open market or private purchase
|
Indirect |
2,426,070
+4.55%
|
$4,852,140
$2.5 P/Share
|
|
Aug 05
2022
|
Invus Us Partners LLC Director |
BUY
Open market or private purchase
|
Indirect |
147,390
+2.63%
|
$294,780
$2.5 P/Share
|
|
Aug 01
2022
|
Raymond Debbane Director |
BUY
Open market or private purchase
|
Indirect |
982,600
+15.63%
|
$1,965,200
$2.5 P/Share
|
|
Aug 01
2022
|
Invus Us Partners LLC Director |
BUY
Open market or private purchase
|
Indirect |
982,600
+15.63%
|
$1,965,200
$2.5 P/Share
|
|
Aug 01
2022
|
Artal International S.C.A. |
BUY
Open market or private purchase
|
Indirect |
16,173,800
+25.03%
|
$32,347,600
$2.5 P/Share
|